ANDA 75929, held by PharmoBedient. Acetaminophen; Butalbital; Caffeine; Codeine Phosphate.
As of Nov 18, 2026, ANDA 75929 (Butalbital, Acetaminophen, Caffeine And Codeine Phosphate), held by PharmoBedient, was first approved by FDA on Apr 22, 2002, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 22, 2002 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Butalbital, Acetaminophen, Caffeine And Codeine Phosphate325MG;50MG;40MG;30MG ยท capsule;oral | Acetaminophen; Butalbital; Caffeine; Codeine Phosphate | Discontinued |
| Jun 18, 2026 | Supplement 32REMS | Approved | None posted |
| Oct 31, 2024 | Supplement 31REMS | Approved | None posted |
| Sep 18, 2018 | Supplement 24REMS ยท Standard review | Approved | None posted |
| Aug 4, 2014 | Supplement 13Labeling ยท Standard review | Approved | None posted |
| Aug 15, 2013 | Supplement 11Labeling ยท Standard review | Approved | None posted |
| Nov 29, 2011 | Supplement 8Labeling | Approved | None posted |
| Sep 19, 2008 | Supplement 5Labeling | Approved | None posted |
| Feb 15, 2008 | Supplement 4Labeling | Approved | None posted |
| Oct 25, 2007 | Supplement 3Labeling | Approved | None posted |
| Apr 22, 2002 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. โWhat FDA's review saysโ is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters